Pilates versus Gyrotonic Expansion System on chemotherapy-induced peripheral neuropathy and fall risk.

Explore (NY)Jun 29, 2026 (epub)

Ahmed M Elfahl, Heba M Elfeky, Ali Mohamed Ali Ismail

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared the effects of Pilates and Gyrotonic Expansion System (GES) on chemotherapy-induced peripheral neuropathy (CIPN) and fall risk in 96 cancer survivors. After 12 weeks, both exercise groups showed significant pain reduction, with Pilates also improving grip strength beyond the minimum clinically important difference (MCID).

Key findings

  • Pilates and GES groups both achieved significant pain reduction with confidence intervals of (1.5: 3.38) and (1.51: 3.39), respectively.
  • The Pilates group demonstrated a significant improvement in grip strength, exceeding the MCID.
  • Both exercise groups surpassed the MCID on the Four-Square Step Test, indicating meaningful gains in functional mobility.

Why it matters

Chemotherapy-induced peripheral neuropathy can severely impact quality of life and increase fall risk in cancer survivors. Effective exercise interventions like Pilates may help mitigate these effects, enhancing patient outcomes.

Source

Published in Explore (NY). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.